What is the dosage of Xeomin?

Xeomin is available in 2 dosages, including 100 unt Injection and 50 unt Injection

What does Xeomin treat?

Xeomin treats Blepharospasm, Dystonia, Fissure in Ano, Muscle Rigidity, Genetic Skin Diseases and Strabismus

What is Xeomin made of?

Xeomin contains botulinum toxin type A which is a Acetylcholine Release Inhibitor

How is Xeomin administered?

Xeomin is administered as a Injectable

What is Xeomin mechanism of action?

Xeomin mechanism of action is Acetylcholine Release Inhibitors

Dosage & Administration Drug label Samples Prior authorization Financial assistance

Patient education

Xeomin

(botulinum toxin type A)

incobotulinumtoxinA 100 UNT Injection [Xeomin]incobotulinumtoxinA 50 UNT Injection [Xeomin]

BLACK BOX WARNING

Dosage & administration

Chronic Sialorrhea:

* Chronic Sialorrhea in Adults: the recommended total dose is 100 Units per treatment session consisting of 30 Units per parotid gland and 20 Units per submandibular gland, no sooner than every 16 weeks
* Chronic Sialorrhea in Pediatric Patients: the recommended dose is based on body weight administered in a 3:2 dose ratio into the parotid and submandibular glands, respectively, no sooner than every 16 weeks; ultrasound guidance recommended

Upper limb spasticity, cervical dystonia, and blepharospasm: the optimum dose, frequency, and number of injection sites in the treated muscle(s) should be based on severity and prior treatment response in patients previously treated with botulinum toxin; individualize dosing for each patient:

* Upper Limb Spasticity in Adults: the recommended total dose is up to 400 Units, divided among affected muscles
* Upper Limb Spasticity in Pediatric Patients, excluding spasticity caused by cerebral palsy: the recommended total dose is 8 Units/kg (maximum 200 Units) per single upper limb or 16 Units/kg (maximum 400 U) in both upper limbs, divided among affected muscles
* Cervical Dystonia: the recommended initial dose is 120 Units per treatment session
* Blepharospasm: the recommended initial dose is 50 Units (25 Units per eye)

Glabellar Lines: the recommended dose is 20 Units per treatment session, divided into five equal intramuscular injections of 4 Units each (two injections in each corrugator muscle and one injection in the procerus muscle; wait a minimum of three months before retreatment

Reconstituted XEOMIN:

* Is intended for intramuscular or intraglandular injection in the parotid and submandibular glands only
* Use for only one injection session and for only one patient
* Instructions are specific for 50 Unit, 100 Unit, and 200 Unit vials
* Store in a refrigerator (2°C to 8°C) and use within 24 hours

Xeomin prescribing information

Have more Xeomin questions?

Submit MSL Request

Learn More

Need to report a Xeomin issue?

ONLINE FORMReport adverse event

Learn More

samples

Request Xeomin samples

NOT PROVIDED BY BRANDView Online Sample Form

Learn More

prior authorization

Xeomin Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Learn More

Benefits investigation

Benefit Investigation Support

Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information

Learn More

financial assistance

Xeomin Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Enroll in Patient Savings Program - For patients using specialty pharmacy

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Xeomin Patient Assistance Program Application

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Xeomin Patient education

Getting started on Xeomin

NOT PROVIDED BY BRANDInstructions For Use - Upper Limb Spasticity

NOT PROVIDED BY BRANDInstructions For Use - Cervical Dystonia

NOT PROVIDED BY BRANDInstructions For Use - Blepharospasm

NOT PROVIDED BY BRANDInstructions For Use - Chronic Sialorrhea (Adults)

NOT PROVIDED BY BRANDInstructions For Use - Chronic Sialorrhea (Pediatrics)

NOT PROVIDED BY BRANDInstructions For Use - Upper Limb Spasticity (excluding spasticity caused by cerebral palsy) in Pediatrics

Patient toolkit

Patient Stories - Adults

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient Stories - Pediatric

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

About Xeomin

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Xeomin

Dosage & administration

Most viewed Xeomin resources

drug label

Xeomin prescribing information

Have more Xeomin questions?

Need to report a Xeomin issue?

samples

Request Xeomin samples

Is my patient elegible for Xeomin samples?

How do I find out who my Xeomin rep is?

prior authorization

Xeomin Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Xeomin Financial assistance options

Co-pay savings program

Overview

Patient benefit

Patient eligibility

How to sign up

Bridge program

Overview

Patient benefit

Patient eligibility

How to sign up

Foundation programs

Overview

Patient benefit

Patient eligibility

How to sign up

patient education

Xeomin Patient education

Getting started on Xeomin

Patient toolkit

Can't find what you're looking for?